{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T22:26:33Z","timestamp":1785018393753,"version":"3.55.0"},"reference-count":35,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T00:00:00Z","timestamp":1668643200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Patients with versus without atopic dermatitis may have a greater risk of cardiovascular events, and the risk increases with severity of atopic dermatitis. The incidence of cardiovascular events in the population of patients with moderate-to-severe atopic dermatitis is largely unknown. This retrospective study evaluates incidence rates of cardiovascular events in patients aged \u226512 years with moderate-to-severe atopic dermatitis in a cohort of Kaiser Permanente Northern California health care system members without recognized risk factors for adverse events. Patients with moderate-to-severe atopic dermatitis, as defined by dermatologist-rendered code and prescription history between 2007 and 2018, were included. Major adverse cardiovascular events, venous thrombotic events, deep vein thrombosis, and pulmonary embolisms were identified via International Classification of Diseases codes. Stratification variables included age, sex, race, smoking history, and diabetes. Incidence rates per 1000 person-years were calculated by the number of patients with an incident event divided by the total person-years of observation. Among 8197 patients with moderate-to-severe atopic dermatitis, incidence rates per 1000 person-years (95% confidence interval) for major adverse cardiovascular events, venous thrombotic events, deep vein thrombosis, and pulmonary embolism were: 2.6 (2.1\u20133.2), 2.0 (1.5\u20132.5), 1.6 (1.2\u20132.1), and 0.7 (0.5\u20131.0), respectively. Incidence rates for all events were higher for older versus younger patients, patients with versus without diabetes, former smokers versus patients who had never smoked, and men versus women, except for pulmonary embolisms, which were higher in women. This study estimated the incidence of cardiovascular events in patients with moderate-to-severe atopic dermatitis and provides valuable information for clinicians.<\/jats:p>","DOI":"10.1371\/journal.pone.0277469","type":"journal-article","created":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T18:42:14Z","timestamp":1668710534000},"page":"e0277469","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":16,"title":["Rates of cardiovascular events among patients with moderate-to-severe atopic dermatitis in an integrated health care system: A retrospective cohort study"],"prefix":"10.1371","volume":"17","author":[{"given":"Monique M.","family":"Hedderson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam M.","family":"Asgari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles P.","family":"Quesenberry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sneha","family":"Sridhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Geier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2994-1341","authenticated-orcid":true,"given":"Adina R.","family":"Lemeshow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2022,11,17]]},"reference":[{"issue":"1","key":"pone.0277469.ref001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41572-018-0001-z","article-title":"Atopic dermatitis","volume":"4","author":"S Weidinger","year":"2018","journal-title":"Nat Rev Dis Primers"},{"issue":"12","key":"pone.0277469.ref002","doi-asserted-by":"crossref","first-page":"adv00160","DOI":"10.2340\/00015555-3510","article-title":"Prevalence and incidence of atopic dermatitis: A systematic review","volume":"100","author":"S Bylund","year":"2020","journal-title":"Acta dermato-venereologica"},{"issue":"1","key":"pone.0277469.ref003","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/all.12268","article-title":"Atopic dermatitis and the atopic march revisited","volume":"69","author":"SC Dharmage","year":"2014","journal-title":"Allergy"},{"issue":"3","key":"pone.0277469.ref004","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.anai.2018.07.006","article-title":"Patient burden and quality of life in atopic dermatitis in US adults: A population-based cross-sectional study","volume":"121","author":"JI Silverberg","year":"2018","journal-title":"Annals of allergy, asthma & immunology: official publication of the American College of Allergy, Asthma, & Immunology"},{"issue":"4","key":"pone.0277469.ref005","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.jaip.2018.11.043","article-title":"Health Utility Scores of Atopic Dermatitis in US Adults","volume":"7","author":"JI Silverberg","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"pone.0277469.ref006","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.jid.2018.08.028","article-title":"Atopic Dermatitis in America Study: A Cross-Sectional Study Examining the Prevalence and Disease Burden of Atopic Dermatitis in the US Adult Population","volume":"139","author":"ZC Chiesa Fuxench","year":"2019","journal-title":"J Invest Dermatol"},{"issue":"5","key":"pone.0277469.ref007","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/j.jaci.2020.12.001","article-title":"Atopic eczema in adulthood and mortality: UK population-based cohort study, 1998\u20132016","volume":"147","author":"RJ Silverwood","year":"2021","journal-title":"The Journal of Allergy and Clinical Immunology"},{"issue":"10","key":"pone.0277469.ref008","first-page":"3500","article-title":"A preliminary 18F-FDG-PET\/MRI study shows increased vascular inflammation in moderate-to-severe atopic dermatitis","volume":"8","author":"B Ungar","year":"2020","journal-title":"Allergy Clin Immunol: In Practice"},{"issue":"5","key":"pone.0277469.ref009","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1016\/j.jaci.2018.11.030","article-title":"Atopic eczema and major cardiovascular outcomes: A systematic review and meta-analysis of population-based studies","volume":"143","author":"A Ascott","year":"2019","journal-title":"The Journal of Allergy and Clinical Immunology"},{"issue":"5","key":"pone.0277469.ref010","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.jid.2016.11.031","article-title":"Association of atopic dermatitis with cardiovascular risk factors and diseases","volume":"137","author":"M Standl","year":"2017","journal-title":"The Journal of investigative dermatology"},{"issue":"5","key":"pone.0277469.ref011","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.anai.2018.07.042","article-title":"Association of atopic dermatitis with allergic, autoimmune, and cardiovascular comorbidities in US adults","volume":"121","author":"JI Silverberg","year":"2018","journal-title":"Annals of allergy, asthma & immunology: official publication of the American College of Allergy, Asthma, & Immunology"},{"issue":"2","key":"pone.0277469.ref012","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.anai.2019.04.020","article-title":"Comorbidities and the impact of atopic dermatitis","volume":"123","author":"JI Silverberg","year":"2019","journal-title":"Annals of allergy, asthma & immunology: official publication of the American College of Allergy, Asthma, & Immunology"},{"issue":"3","key":"pone.0277469.ref013","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.jaci.2014.11.023","article-title":"Eczema and cardiovascular risk factors in 2 US adult population studies","volume":"135","author":"JI Silverberg","year":"2015","journal-title":"The Journal of Allergy and Clinical Immunology"},{"issue":"3","key":"pone.0277469.ref014","doi-asserted-by":"crossref","first-page":"100","DOI":"10.12788\/j.sder.2017.036","article-title":"Atopic dermatitis: pathogenesis","volume":"36","author":"E Guttman-Yassky","year":"2017","journal-title":"Semin Cutan Med Surg"},{"issue":"4","key":"pone.0277469.ref015","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/exd.13336","article-title":"Systemic immune mechanisms in atopic dermatitis and psoriasis with implications for treatment","volume":"27","author":"E Guttman-Yassky","year":"2018","journal-title":"Experimental dermatology"},{"issue":"5","key":"pone.0277469.ref016","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1080\/1744666X.2017.1298443","article-title":"Commonality of the IL-4\/IL-13 pathway in atopic diseases","volume":"13","author":"NA Gandhi","year":"2017","journal-title":"Expert Rev Clin Immunol"},{"issue":"1","key":"pone.0277469.ref017","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.jaci.2016.01.015","article-title":"Risk of myocardial infarction, ischemic stroke, and cardiovascular death in patients with atopic dermatitis","volume":"138","author":"YMF Andersen","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"pone.0277469.ref018","volume-title":"Similarity of the adult Kaiser Permanente membership in northern California to the insured and general population in northern California: Statistics from the 2011 California health interview survey","author":"NP Gordon","year":"2015"},{"issue":"2","key":"pone.0277469.ref019","first-page":"338","article-title":"Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis","volume":"70","author":"LF Eichenfield","year":"2014","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"8","key":"pone.0277469.ref020","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1161\/CIRCULATIONAHA.118.035550","article-title":"Sex Differences in the Prevalence of, and Trends in, Cardiovascular Risk Factors, Treatment, and Control in the United States, 2001 to 2016","volume":"139","author":"SAE Peters","year":"2019","journal-title":"Circulation"},{"issue":"6","key":"pone.0277469.ref021","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s40257-017-0293-x","article-title":"Association between inflammatory skin disease and cardiovascular and cerebrovascular co-morbidities in US adults: Analysis of nationwide inpatient sample data","volume":"18","author":"MC Kwa","year":"2017","journal-title":"American journal of clinical dermatology"},{"issue":"4","key":"pone.0277469.ref022","doi-asserted-by":"crossref","first-page":"15","DOI":"10.7812\/TPP\/15-225","article-title":"The Kaiser Permanente Northern California adult member health survey","volume":"20","author":"N Gordon","year":"2016","journal-title":"Perm J"},{"issue":"1","key":"pone.0277469.ref023","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/ije\/dyn040","article-title":"Cohort Profile: The Diabetes Study of Northern California (DISTANCE)\u2014objectives and design of a survey follow-up study of social health disparities in a managed care population","volume":"38","author":"HH Moffet","year":"2009","journal-title":"Int J Epidemiol"},{"issue":"19","key":"pone.0277469.ref024","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1001\/jama.287.19.2519","article-title":"Ethnic disparities in diabetic complications in an insured population","volume":"287","author":"AJ Karter","year":"2002","journal-title":"Jama"},{"issue":"9","key":"pone.0277469.ref025","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.2337\/diacare.20.9.1396","article-title":"Excess costs of medical care for patients with diabetes in a managed care population","volume":"20","author":"JV Selby","year":"1997","journal-title":"Diabetes Care"},{"issue":"8","key":"pone.0277469.ref026","doi-asserted-by":"crossref","first-page":"e254","DOI":"10.1161\/CIR.0000000000000950","article-title":"Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association","volume":"143","author":"SS Virani","year":"2021","journal-title":"Circulation"},{"issue":"1","key":"pone.0277469.ref027","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.amjmed.2004.01.018","article-title":"Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology","volume":"117","author":"M Cushman","year":"2004","journal-title":"Am J Med"},{"issue":"4","key":"pone.0277469.ref028","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2007.02450.x","article-title":"Incidence and mortality of venous thrombosis: a population-based study","volume":"5","author":"IA Naess","year":"2007","journal-title":"J Thromb Haemost"},{"issue":"4","key":"pone.0277469.ref029","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1053\/euhj.2001.2898","article-title":"Predicting cardiovascular risk in the elderly in different European countries","volume":"23","author":"S Houterman","year":"2002","journal-title":"Eur Heart J"},{"issue":"8","key":"pone.0277469.ref030","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.jacc.2008.03.066","article-title":"Measures of obesity and cardiovascular risk among men and women","volume":"52","author":"RP Gelber","year":"2008","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"pone.0277469.ref031","doi-asserted-by":"crossref","first-page":"e000298","DOI":"10.1136\/bmjgh-2017-000298","article-title":"Sex differences in coronary heart disease and stroke mortality: a global assessment of the effect of ageing between 1980 and 2010","volume":"2","author":"SH Bots","year":"2017","journal-title":"BMJ global health"},{"issue":"9","key":"pone.0277469.ref032","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.amjmed.2014.03.041","article-title":"Secular trends in occurrence of acute venous thromboembolism: the Worcester VTE study (1985\u20132009)","volume":"127","author":"W Huang","year":"2014","journal-title":"Am J Med"},{"issue":"11","key":"pone.0277469.ref033","doi-asserted-by":"crossref","first-page":"e011870","DOI":"10.1136\/bmjopen-2016-011870","article-title":"Hospital-diagnosed atopic dermatitis and long-term risk of myocardial infarction: a population-based follow-up study","volume":"6","author":"JL Riis","year":"2016","journal-title":"BMJ open"},{"issue":"2","key":"pone.0277469.ref034","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3109\/07853890.2013.870018","article-title":"Atopic dermatitis and risk of ischemic stroke: A nationwide population-based study","volume":"46","author":"VY-F Su","year":"2014","journal-title":"Ann Med"},{"key":"pone.0277469.ref035","first-page":"1","article-title":"Integrated safety analysis of abrocitinib for the treatment of moderate-to-severe atopic dermatitis from the phase II and Phase III clinical trial program","author":"EL Simpson","year":"2021","journal-title":"Am J Clin Dermatol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0277469","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T18:42:51Z","timestamp":1668710571000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0277469"}},"subtitle":[],"editor":[{"given":"Dong Keon","family":"Yon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,11,17]]},"references-count":35,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,11,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0277469","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,17]]}}}